Catalyst
Slingshot members are tracking this event:
Daichii Sankyo (DSNKY) Presents Phase 1 Data Evaluating DS-8201a in T-DM1 Pre-Treated Breast Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| DSNKY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 11, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Data, Novel Investigational, Her2-targeting Antibody Drug Conjugate, Ds-8201a, T-dm1 Pre-treated Breast Cancer, European Society For Medical Oncology
